Adventus Completes Full Repayment Of Credit Facility To Trafigura-August 2024-www.financetom.com

Adventus Completes Full Repayment Of Credit Facility To Trafigura

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Adventus Completes Full Repayment Of Credit Facility To Trafigura

May 30, 2024 2:03 PM

04:32 PM EDT, 05/30/2024 (MT Newswires) -- Adventus Mining ( ADVZF ) on Thursday said it fully repaid and settled US$6.3 million owing under a credit facility from Trafigura PTE.

The company said it used from a $25.6 million private placement that closed May 1, 2024, ahead of its planned acquisition by Silvercorp Metals (SVM.TO)

Adventus shares closed down $0.01 to $0.54 on the Toronto Stock Exchange.

Previous page： Abercrombie & Fitch Lifts Full-Year Guidance as Second-Quarter Results Top Views Next page： Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Abercrombie & Fitch Lifts Full-Year Guidance as Second-Quarter Results Top Views

Aug 27, 2025

01:20 PM EDT, 08/27/2025 (MT Newswires) -- Abercrombie & Fitch ( ANF ) upgraded its fiscal 2025 outlook on Wednesday after the apparel retailer's second-quarter results exceeded Wall Street's estimates, though earnings fell year over year. The company now expects full-year earnings between $10 and $10.50 per share, lifting the middle point versus its prior outlook of $9.50 to $10.50....

Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial

Aug 27, 2025

On Wednesday, Vor Bio Inc. announced that its collaborator, RemeGen Co., Ltd., achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept in adults with IgA nephropathy (IgAN). IgA nephropathy, also known as Berger’s disease, is an autoimmune kidney disease where abnormal clumps of the antibody immunoglobulin A (IgA) deposit in the kidneys’...

Rheinmetall wants to take over German shipbuilder NVL, Bild reports

Aug 27, 2025

BERLIN, Aug 27 (Reuters) - Defence group Rheinmetall wants to take over German shipbuilder Naval Vessels Luerssen, the German daily Bild reported on Wednesday, citing industry sources. According to Bild, the Luerssen family, who own the shipbuilder, plan to divest its military shipyards in Hamburg, Wilhelmshaven and Wolgast to focus on building megayachts. Rheinmetall's supervisory board intends to consider the...

BRIEF-CCH Holdings Files For U.S IPO With SEC - SEC Filing

Aug 27, 2025

Aug 27 (Reuters) - CCH Holdings Ltd: * CCH HOLDINGS LTD - FILES FOR US IPO WITH SEC - SEC FILING * CCH HOLDINGS LTD - TO APPLY FOR NASDAQ LISTING UNDER SYMBOL 'CCHH' - SEC FILING * CCH HOLDINGS LTD: CATHAY SECURITIES INC IS UNDERWRITER TO IPO ;)) ...